摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

azane;7-methoxy-1-methyl-9H-pyrido[3,4-b]indole

中文名称
——
中文别名
——
英文名称
azane;7-methoxy-1-methyl-9H-pyrido[3,4-b]indole
英文别名
——
azane;7-methoxy-1-methyl-9H-pyrido[3,4-b]indole化学式
CAS
——
化学式
C13H15N3O
mdl
——
分子量
229.28
InChiKey
HKOZKLXFQVUJGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    38.9
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH
    申请人:Osteoqc Inc.
    公开号:EP2968284A2
    公开(公告)日:2016-01-20
  • KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
    申请人:Icahn School of Medicine at Mount Sinai
    公开号:EP3768267A1
    公开(公告)日:2021-01-27
  • [EN] ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH<br/>[FR] DÉRIVÉS D'ALKYL-AMINE HARMINE POUR FAVORISER LA CROISSANCE OSSEUSE
    申请人:OSSIFI INC
    公开号:WO2014153203A2
    公开(公告)日:2014-09-25
    In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula II, or Formula III. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease and cancer, using a compound of Formula I, Formula II, or Formula III.
  • [EN] KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS INHIBITEURS DE KINASE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
    申请人:ICAHN SCHOOL MED MOUNT SINAI
    公开号:WO2019183245A1
    公开(公告)日:2019-09-26
    Described herein are compounds having the following structure: formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof. Also disclosed are compositions containing the compounds, methods of inhibiting activity of DYRKl A in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.
查看更多